Deals•Feb 10, 2026
Merck to Acquire Cidara Therapeutics to Advance Universal Flu Vaccine
Merck announced it will acquire San Diego‑based biotech Cidara Therapeutics, which has developed a long‑acting preventive flu treatment. The deal, aimed at bolstering Merck's pipeline for a universal flu vaccine, was disclosed without a financial amount.
Vox » Technology (Recode)